The assessment of the use of eco-friendly nets to ensure sustainable cabbage seedling production in Africa

High seed cost accompanied by poor germination and seedling performance renders cabbage nursery and field production enterprises unsustainable to many small-scale growers in tropical and sub-tropical countries. In most nurseries, adverse ecological conditions and pest damage are among the major factors responsible for poor seedling performance. The objective of this study was to test the potential use of eco-friendly net (EFN) covers as a low cost technology for sustainable cabbage seedling production. The study was a two-season experiment conducted using a randomized complete block design with five replications and two treatments. Treatments were: the standard open field transplant production (control) and transplant production under 0.4 mm mesh polyethylene net covering. EFN covering increased both temperature and relative humidity, enhanced seedling growth and reduced insect pest damage. Seed germination and seedling emergence were under the net covering earlier. Higher seed germination and seedling survival were recorded under the EFN treatment, indicating a potential for reducing the seed requirement per unit area of cabbage production. Seedlings grown under the nets had higher stomatal conductance and leaf chlorophyll content; furthermore, they grew taller, with more leaves within a shorter period of time compared to the control seedlings. The use of EFN in cabbage nurseries offers a sustainable technology for enhancing seedling performance by reducing pest infestation, thereby lowering production cost and improving the grower's income. (Résumé d'auteur

A Systematic Review Including an Additional Pediatric Case Report: Pediatric Cases of Mammary Analogue Secretory Carcinoma

Importance Mammary Analogue Secretory Carcinoma (MASC) is a newly characterized salivary gland carcinoma resembling secretory carcinoma of the breast. Prior to being described, MASC was most commonly misdiagnosed as Acinic Cell Carcinoma. Though MASC is predominantly an adult neoplasm, cases have been reported in the pediatric population. Reporting and summarizing of known cases is imperative to understand the prognosis and clinical behavior of MASC. Objective (1) Report a rare case of pediatric MASC. (2) Review and consolidate the existing literature on MASC in the pediatric population. Evidence review Web of Science, Medline, EMBASE, and The Cochrane Library were searched for studies that included pediatric cases of MASC. Data on clinical presentation, diagnosis and management, and pathology were collected from all pediatric cases. Findings Case Report 14 year old with left-sided parotid mass diagnosed as MASC based on histology and immunohistochemistry. He was managed surgically with left superficial parotidectomy with selective neck dissection. Literature review The majority of MASC cases have been identified via retrospective reclassification of previously misclassified salivary gland tumors. Of all the pediatric cases (N=11) of MASC, the female-to-male ratio is 1:1.2 with an age range of 10-17 years old. The most common clinical presentation was a slowly growing, fixed, and painless mass of the parotid gland, often detected incidentally on physical examination. Common pathological features include eosinophilic vacuolated cytoplasm within cystic, tubular, and/or papillary architecture. Immunohistochemistry showed positivity for S100, mammaglobin, cytokeratin 19, and vimentin. The diagnosis was confirmed by the detection of the characteristic ETV6-NTRK6 fusion gene via fluorescent in-situ hybridization (FISH). Only 4 cases discussed treatment. Each of these underwent successful surgical resection alone with or without lymph node dissection. Conclusions and relevance Since the first case of MASC in the pediatric population was described in 2011, only 12 cases, including this one, have been described in the literature. With this paucity of information, much remains unknown regarding this new pathologic diagnosis. The collection of clinical outcomes data of children with MASC is needed to better understand the behavior of this malignancy as well as determine optimal treatment regimens